Tang Capital entities disclose 2.25M Boundless Bio (BOLD) shares in Form 3 filing
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Boundless Bio, Inc. insider filings show that entities affiliated with Tang Capital report initial beneficial ownership of the company’s common stock. The Form 3 indicates indirect holdings of 2,247,512 shares of common stock, held by limited partnership and corporate vehicles associated with Tang Capital.
Kevin Tang is described as the sole manager or director of these entities and has a pecuniary interest in the shares they beneficially own. The filing is an initial ownership report and does not show any new purchases or sales of Boundless Bio stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
TANG KEVIN, TANG CAPITAL MANAGEMENT LLC
Role
null | null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 2,247,512 shares (Indirect, By LP)
Footnotes (1)
- [object Object]
Key Figures
Indirectly owned shares: 2,247,512 shares
1 metrics
Indirectly owned shares
2,247,512 shares
Common Stock beneficially owned through Tang Capital entities
Key Terms
ten percent owner, beneficially owned, pecuniary interest, indirect, +1 more
5 terms
ten percent owner financial
"is_ten_percent_owner": 1"
beneficially owned financial
"The shares are beneficially owned by Tang Capital Partners, LP"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
pecuniary interest financial
"Mr. Tang has a pecuniary interest in the shares beneficially held"
indirect financial
""ownership_type": "indirect""
Form 3 regulatory
"INSIDER FILING DATA (Form 3):"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
FAQ
What does the Boundless Bio (BOLD) Form 3 filed by Tang Capital report?
The Form 3 reports initial beneficial ownership of Boundless Bio common stock by Tang Capital–related entities. It shows indirect holdings of 2,247,512 shares and identifies Kevin Tang’s roles in those entities and his pecuniary interest in the reported holdings.
Is Kevin Tang a ten percent owner of Boundless Bio (BOLD) according to this Form 3?
Yes. The Form 3 identifies Kevin Tang as a ten percent owner of Boundless Bio. His ownership arises through entities he manages or controls, including Tang Capital Management, LLC and several Tang Capital partnership and corporate vehicles that beneficially hold the reported shares.
Does the Boundless Bio (BOLD) Form 3 show any recent insider buying or selling?
No. The Form 3 functions as an initial statement of beneficial ownership rather than a trade report. It lists 2,247,512 shares of common stock held indirectly but does not disclose any purchase, sale, or other transaction changing that ownership position.